Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001485003-16-000144
Filing Date
2016-08-12
Accepted
2016-08-12 16:09:52
Documents
50
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ebio-063016x10q.htm 10-Q 880730
2 EXHIBIT 10.1 ebio-063016x101.htm EX-10.1 927497
3 EXHIBIT 31.1 ebio-063016x311.htm EX-31.1 12096
4 EXHIBIT 31.2 ebio-063016x312.htm EX-31.2 11953
5 EXHIBIT 32.1 ebio-063016x321.htm EX-32.1 7023
12 ebiologoa06.jpg GRAPHIC 8456
  Complete submission text file 0001485003-16-000144.txt   4294110

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ebio-20160630.xml EX-101.INS 530220
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebio-20160630.xsd EX-101.SCH 29473
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ebio-20160630_cal.xml EX-101.CAL 41636
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ebio-20160630_def.xml EX-101.DEF 98344
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebio-20160630_lab.xml EX-101.LAB 370055
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebio-20160630_pre.xml EX-101.PRE 203175
Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36296 | Film No.: 161828315
SIC: 2834 Pharmaceutical Preparations